Recce Pharmaceuticals Ltd
RCE•Health Care•Biotechnology•Last updated: Dec 25
About
Recce Pharmaceuticals Ltd is a biotechnology company focused on the development and commercialization of synthetic anti-infectives. The company is engaged in the research and development of a new class of synthetic antibiotics designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens. Its lead product, RECCE® 327, is designed to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- RCE
Related Shares
Investor Resources
Should you buy Recce Pharmaceuticals Ltd right now?
While RCE looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now